Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,368 | -6,313 | -4,681 | -3,203 | -1,657 |
| Accounts payable and accrued liabilities | -6 | 2 | 81 | 147 | 144 |
| Other Working Capital | -181 | 155 | 114 | 210 | 282 |
| Other Operating Activity | 283 | 1,544 | 1,082 | 617 | 196 |
| Operating Cash Flow | $-1,271 | $-4,612 | $-3,403 | $-2,229 | $-1,035 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6 | 5,141 | 5,141 | 5,141 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -11 |
| Financing Cash Flow | $6 | $5,141 | $5,141 | $5,141 | $-11 |
| Beginning Cash Position | 5,353 | 4,824 | 4,824 | 4,824 | 4,824 |
| End Cash Position | 4,088 | 5,353 | 6,562 | 7,736 | 3,778 |
| Net Cash Flow | $-1,265 | $530 | $1,738 | $2,912 | $-1,046 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,271 | -4,612 | -3,403 | -2,229 | -1,035 |
| Free Cash Flow | -1,271 | -4,612 | -3,403 | -2,229 | -1,035 |